Cradle, a pioneering AI-driven biotechnology company, has raised $73 million to enhance its protein design capabilities, leveraging advanced AI models and high-quality datasets to predict and create proteins with desirable traits. This funding will support the expansion of their operations, including the development of their Amsterdam lab, and underscores the growing interest in AI applications within the biotech and pharmaceutical industries.